Perspective Therapeutics
Price & Volume
Stats
See moreOpen | $0.90 |
Previous Close | $0.88 |
Day Range | $0.83-$0.95 |
52W Range | $0.87-$6.16 |
Market Cap | $100.4M |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $409,000 |
Revenue Growth (YoY) | -72.1% |
Gross Profit (12 Mos) | -$95.7M |
Diluted EPS | -$1.33 |
News
See moreYahoo Finance • 2 months ago
Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck to Evaluate [212Pb]PSV359 in Combination with Keytruda® (Pembrolizumab) in FAP-α Positive Solid Tumors
Yahoo Finance • 3 months ago
Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs
Yahoo Finance • 4 months ago
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026
About
CEO | Mr. Johan M. Spoor |
CFO | Mr. Joel David Sendek |
Address | 2401 Elliott Avenue, Seattle, WA, United States, 98121 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 163 |